brequinar
Term · Oncology and biomedicine · MLC-T-ONC-012111
A synthetic quinolinecarboxylic acid analogue with antineoplastic properties. Brequinar inhibits the enzyme dihydroorotate dehydrogenase, thereby blocking de novo pyrimidine biosynthesis. This agent may also enhance the in vivo antitumor effect of antineoplastic agents such as 5-FU.
| Identifier | MLC-T-ONC-012111 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Bipenquinate |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012111",
"term": "brequinar",
"field": "Oncology and biomedicine",
"definition": "A synthetic quinolinecarboxylic acid analogue with antineoplastic properties. Brequinar inhibits the enzyme dihydroorotate dehydrogenase, thereby blocking de novo pyrimidine biosynthesis. This agent may also enhance the in vivo antitumor effect of antineoplastic agents such as 5-FU.",
"synonyms": [
"Bipenquinate"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/brequinar/"
}
Record 3,849 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.